|
Volumn 2, Issue 2, 2008, Pages 122-132
|
Hot flashes in prostate cancer: State of the science
|
Author keywords
Hormone ablation; Hot flashes; Men; Prostate cancer; Quality of life
|
Indexed keywords
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PROSTATE SPECIFIC ANTIGEN;
ADAPTIVE BEHAVIOR;
AGE DISTRIBUTION;
AGED;
ARTICLE;
BLOOD;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
COGNITIVE DEFECT;
HOT FLUSH;
HUMAN;
INCIDENCE;
INTERVENTION STUDY;
MALE;
MEN'S HEALTH;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PROGNOSIS;
PROSTATE TUMOR;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SLEEP DISORDER;
ADAPTATION, PSYCHOLOGICAL;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
COGNITION DISORDERS;
HOT FLASHES;
HUMANS;
INCIDENCE;
INTERVENTION STUDIES;
MALE;
MEN'S HEALTH;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
SLEEP DISORDERS;
|
EID: 43149126083
PISSN: 15579883
EISSN: 15579891
Source Type: Journal
DOI: 10.1177/1557988306298802 Document Type: Article |
Times cited : (34)
|
References (85)
|